Data independent acquisition (DIA) has been an important catalyst for transferring mass spectrometry (MS)-based omics from a discovery-focused science to one that more wholly enables longitudinal ...
Spectronaut® 18 makes DIA proteomics projects more efficient and scalable than ever for all mass spectrometry instrument types Novel research with TrueDiscovery™ and TrueTarget™ demonstrates the ...
Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the ...
SWATH DIA (data independent acquisition) has emerged as an LC-MS/MS workflow that capitalizes on the speed and sensitivity gains that have been achieved with modern mass spectrometers. SWATH DIA can ...
The new CRO facility for proteomics services in Newton, Massachusetts ensures closer proximity to US customers Biognosys’ center of excellence for proteomics innovation at its headquarters near Zurich ...
Integrating high-throughput proteomics into pharmaceutical R&D has shifted how laboratories approach target identification and disease modeling. Mapping complex protein networks provides a functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results